G1 control gene status is frequently altered in resectable non-small cell lung cancer

International Journal of Cancer

Volumn 74, Issue 5, 1997, Pages 556-562

  Betticher, Daniel C ^a   White, Gavin R M ^b   Vonlanthen, Silvia ^a   Liu, Xuan ^a   Kappeler, Andreas ^a   Altermatt, Hans J ^a   Thatcher, Nick ^b   Heighway, Jim ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CELL CYCLE G1 PHASE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; BIOSYNTHESIS; DNA METHYLATION; DOWN REGULATION; EXON; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DOWN-REGULATION; EXONS; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENES, RETINOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN;

EID: 0030611934     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971021)74:5<556::AID-IJC14>3.0.CO;2-4     Document Type: Article

References (23)

1. BETTICHER, D.C., Cyclin D1, another molecule of the year? Ann. Oncol., 7, 223-225 (1996).
2. BETTICHER, D.C., HEIGHWAY, J., HASLETON, P.S., ALTERMATT, H.J., RYDER, W.D.J., CERNY, T. and THATCHER, N., Prognostic significance of CCND1 (cyclin D1) overexpression in primay resected non-small cell lung cancer. Brit. J. Cancer, 73, 294-300 (1996).
3. BORG, A., ZHANG, Q.X., ALM, P., OLSSON, H. and SELLBERG, G., The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res., 52, 2991-2994 (1992).
4. BRINGUIER, P.P., TAMIMI, Y., SCHUURING, E. and SCHALKEN, J., Expression of cyclin D1 and EMS1 in bladder tumours: relationship with chromosome 11q13 amplification. Oncogene, 12, 1747-1753 (1996).
5. DE BOER, C.J., SCHUURING, E., DREEF, E., PETERS, G., BARTEK, J., KLUIN, P.M. and KRIEKEN, J.H.J.M., Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood, 86, 2715-2723 (1995).
6. GILLETT, C., FANTL, V., SMITH, R., FISHER, C., BARTEK, J., DICKSON, C., BARNES, D. and PETERS, G., Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817 (1994).
7. GILLETT, C., SMITH, P., GREGORY, W., RICHARDS, M., MILLIS, R., PETERS, G. and BARNES, D., Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer, 69, 92-99 (1996).
8. GONZALEZ-ZULUETA, M., BENDER, C.M., YANG, A.S., NGUYEN, T., BEART, R.W., VAN TORNOUT, J.M. and JONES, P.A., Methylation of the 5′ CpG island of the p16/CDKn2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
9. HEIGHWAY, J., BETTICHER, D.C., HOBAN, P., ALTERMATT, H.J. and COWEN, R., Co-amplification in tumours of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene and a novel human gene, KRAG. Genomics, 35, 207-214 (1996).
10. KAMB, A., GRUIS, N.A., WAEVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
11. KIM, T.M., BENEDICT, W.F., XU, H.J., HU, S.X., GOSEWEHR, J., VELICESCU, M., YIN, E., ZHENG, J., D'ABLAING, G. and DUBEAU, L., Loss of heterozygpsity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res., 54, 605-609 (1994).
12. LENGAUER, C., KINZLER, K.W. and VOGELSTEIN, B., DNA methylation and genetic instability in colorectal cancer cells. Proc. nat. Acad. Sci. (Wash.). 94, 2545-2550 (1997).
13. MAHELANDSMO, G.M., BERNER, J.M., FLORENES, V.A., FORUS, A., HOVIG, E., FODSTAD, O. and MYKLEBOST, O., Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1. Brit. J. Cancer. 72, 393-398 (1995).
14. NEVILLE, E.M., STEWART, M., MYSKOW, M., DONNELLY, R.J. and FIELD, J.K., Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene, 11, 582-585 (1995).
15. OTTERSON, G.A., KHLEIF, S.N., CHEN, W., COXON, A.B. and KAYE, F.J., CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene, 11, 1211-1216 (1995).
16. SAKAGUCHI, M., FUJII, Y., HIRABAYASHI, H., YOON, H.E., KOMOTO, Y., OUE, T., KUSAFUKA, T., OKADA, A. and MATSUDA, H., Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int. J. Cancer, 65, 442-445 (1996).
17. SCHUURING, E., The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene. 159, 83-96 (1995).
18. SHAPIRO, G.I., EDWARDS, C.D., KOBZIK, L., GODLESKI, J., RICHARDS, W., SUGARBAKER, D.J. and ROLLINS, B.J., Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res., 55, 505-509 (1995).
19. SHERR, C.J., Cancer cell cycles. Science, 274, 1672-1677 (1996).
20. UICC-AMERICAN JOINT COMMITTEE ON CANCER, Manual for Staging of Cancer (3rd ed.) J.B. Lippincott, Philadelphia (1987).
21. XU, H.J., Altered retinoblastoma (Rb) protein expression in human malignancies. Adv. Anat. Pathol., 2, 213-226 (1995).
22. XU, H.J., QUINLAN, D.C., DAVIDSON, A.G., HU, S.X., SUMMERS, C.L., LI, J. and BENEDICT, W.F., Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. nat. Cancer Inst., 86, 695-699 (1994).
23. ZHOU, X., TARMIN, L., YIN, J., JIANG, H.Y., SUZUKI, H., RHYU, M.G., ABRAHAM, J.M. and MELTZER, S.J., The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741 (1994).